GlassScriptPhysician profile
Todd Y Liu
NPI 1396733812
$1,243.34
in general payments reported to CMS, 2019-2025
24 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $119 · 2021: $41.74 · 2022: $158 · 2023: $392 · 2024: $117 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.19 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $268.16 | 2023-2025 | Veozah |
| Abbvie INC. | $130.61 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.81 | 2019-2020 | |
| Hologic Sales and Service, LLC | $75.88 | 2020-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $68.84 | 2023-2025 | Myfembree |
| Organon LLC | $65.62 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $64.58 | 2022-2025 | Slynd |
| Millicent US INC | $52.20 | 2019-2025 | Intrarosa, Femlyv |
| Medtronic, INC. | $47.55 | 2022 | |
| Evofem Biosciences, INC. | $46.57 | 2022-2024 | Phexxi |
| Therapeuticsmd, INC. | $41.53 | 2019-2021 | |
| Abbott Laboratories | $39.51 | 2023 | Freestyle Libre 3 |
| Cumberland Pharmaceuticals, INC. | $38.58 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $32.54 | 2019-2025 | Gardasil 9 |
| Exact Sciences Corporation | $30.02 | 2023 | Cologuard Collection Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $28.18 | 2024-2025 | |
| Roche Diagnostics Corporation | $19.51 | 2019 | |
| Amgen INC. | $18.44 | 2025 | Evenity |
| Lilly USA, LLC | $17.82 | 2025 | Zepbound |
| Organogenesis INC. | $16.87 | 2025 | Puraply Wound Matrix |
| Pfizer INC. | $16.06 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $14.38 | 2022 | |
| Olympus America INC. | $14.38 | 2019 | |
| Myovant Sciences INC. | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.